Gentherm Incorporated

Gentherm Incorporated (THRM) Market Cap

Gentherm Incorporated has a market capitalization of $1.24B.

Price: $40.58

-1.74 (-4.11%)

Market Cap: 1.24B

NASDAQ · time unavailable

CEO: William T. Presley

Sector: Consumer Cyclical

Industry: Auto - Parts

IPO Date: 1993-06-10

Website: https://gentherm.com

Gentherm Incorporated (THRM) - Company Information

Market Cap: 1.24B|Sector: Consumer Cyclical

Company Profile

Gentherm Incorporated is a company dedicated to the creation, production, and sale of advanced thermal management technologies. Its operations are divided into two principal business segments: Automotive and Medical. The Automotive segment offers an extensive range of climate comfort systems, encompassing active heating and cooling solutions for seats (utilizing heaters, blowers, and thermoelectric devices for precise temperature regulation), heated steering wheels, and specialized thermal comfort products for areas like the neck, door panels, armrests, cupholders, and storage bins. This segment also develops integrated electronic components, including proprietary electronic control units (ECUs) and software essential for these comfort features, as well as general automotive electronic and software systems like memory seat modules. Additionally, Gentherm provides battery performance solutions, which include cell connecting devices, advanced battery cable technologies, and thermal management systems designed to heat and cool 12-volt, 48-volt, and high-voltage automotive batteries and modules. Its clientele in this segment primarily consists of light vehicle original equipment manufacturers (OEMs), key first-tier suppliers (such as automotive seat manufacturers), and aftermarket seat distributors and installers. The Medical segment focuses on delivering systems for managing patient temperature. Gentherm has a wide international footprint, with its products and services available across the United States, Germany, Canada, China, Hungary, Japan, South Korea, Romania, Macedonia, Malta, Mexico, the United Kingdom, Ukraine, and Vietnam. Founded in 1991 as Amerigon Incorporated, the company rebranded to Gentherm Incorporated in September 2012 and is based in Northville, Michigan.

Analyst Sentiment

69%
Buy

From 9 Active Polls

1Y Forecast: $45.25

▲ +11.5% Potential Upside

Consensus Target Metrics

Low Bound

$34

Median

$44

High Bound

$59

Average

$45

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$45.25
▲ +11.51% Upside
Low Target
$34.00
-16% Risk
Median Target
$44.00
8% Mid
High Target
$59.00
45% Max
Consensus
Buy
8 / 15 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024
Market Cap ($M)1,2441,0458481,1091,0388668231,2341,452
Enterprise Value ($M)1,3561,1579441,2431,1331,0089821,3651,552
Price to Earnings Ratio (P/E)46.7560.9149.6192.7817.38453.37-1591.6719.9622.82
Price/Earnings-to-Growth Ratio (PEG)10.6817.398.3675.54-5975.76
Price to Sales Ratio (P/S)0.792.512.152.902.712.312.333.503.91
Price to Book Ratio (P/B)1.721.451.181.541.451.241.272.002.20
Price to Free Cash Flow Ratio (P/FCF)30.44-845.17-79.27174.5822.3423.92-29.0293.2655.22
Enterprise Value to Sales (EV/Sales)2.782.403.252.962.692.783.874.18
Enterprise Value to EBITDA (EV/EBITDA)11.8446.0438.5745.2830.2325.6526.7734.2932.11
Debt to Equity Ratio0.980.450.380.410.350.390.500.430.38

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 GENTHERM INC (THRM) — Investment Overview

🧩 Business Model Overview

Gentherm designs and manufactures thermal comfort and thermal management systems that are embedded into customer vehicles (and, to a lesser extent, other industrial/embedded applications). The value chain is driven by automotive “design-in” programs: the company works with OEMs during vehicle development, qualifies products to stringent safety/performance requirements, and then supplies systems through vehicle production. Products are integrated into seats and cabins (heated/cooled comfort), as well as powertrain-related thermal applications (including battery thermal support in electrified platforms).

Operating economics depend on engineering and qualification expertise upfront, followed by recurring supply of component and system content per vehicle over the program life. Once a thermal architecture is selected, switching away becomes difficult because the OEM must re-engineer interfaces, restart validation, and accept performance and safety re-qualification costs.

💰 Revenue Streams & Monetisation Model

Revenue is primarily B2B supply of thermal systems and components to automotive OEMs and tier customers. Monetisation is largely program-based: revenue scales with vehicle production volumes and the degree of system content per vehicle.

Margin drivers typically include:

  • Content per vehicle and product mix (higher-value active thermal features and integrated modules support better gross margin profiles).
  • Cost absorption over production ramps (qualification-related engineering costs and early-phase inefficiencies amortize as volumes scale).
  • Manufacturing efficiency (yield, scrap, and component sourcing discipline materially influence contribution margins).

The business model is not inherently “contracted recurring” in the software sense, but automotive supply programs create long-duration revenue visibility relative to typical industrial component businesses, subject to launch timing and production volumes.

🧠 Competitive Advantages & Market Positioning

Gentherm’s core moat is embedded switching costs created by the automotive design-in process, supported by technical differentiation and intangible assets (thermal engineering know-how, product qualification expertise, and likely IP across control/thermal technologies).

  • Switching Costs (Hard to Replace Once Designed-In): Competitors face qualification and revalidation hurdles for safety-critical thermal systems, along with integration risk around seat/cabin architecture and vehicle electrical/controls compatibility.
  • Intangible Assets: Thermal control algorithms, materials/process know-how, and system integration experience reduce engineering cycles for customers and support faster program ramp execution.

Competitive benchmarking:

Gentherm competes in automotive thermal comfort and thermal management content against companies such as:

  • Valeo (broader thermal systems and automotive electrification-related offerings, often with larger platform scope).
  • Denso (integrated automotive systems including thermal and powertrain-adjacent components at scale).
  • Webasto (vehicle heating/thermal solutions with strong heating expertise).

Compared with these peers, Gentherm’s positioning emphasizes smart thermal solutions and system-level integration (notably in vehicle comfort and thermally-related electrification needs), where selection and continued sourcing can become “stickier” once a thermal architecture is locked into a platform.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, Gentherm’s addressable market is supported by several durable trends:

  • Electrification and battery thermal requirements: EV platforms increase the importance of battery thermal support, cabin energy efficiency, and more capable thermal management strategies.
  • Rising demand for active thermal comfort: Comfort expectations expand beyond passive heating into more sophisticated, energy-aware thermal features.
  • Product content expansion per vehicle: OEMs increasingly differentiate using thermal experience (seat comfort, steering/wrap features, multi-zone thermal control).
  • Vehicle platform proliferation and longer program lives: Once design wins are established, program duration can extend revenue generation through successive model years.

TAM expansion is driven less by one-time replacement and more by per-vehicle content growth across internal combustion and electrified fleets, with electrification acting as an additional tailwind.

⚠ Risk Factors to Monitor

  • Automotive demand cyclicality: Vehicle production volumes can fluctuate, pressuring near-term revenue and margin via absorption and ramp dynamics.
  • Program execution and launch timing risk: Qualification delays, design changes, or ramp underperformance can reduce profitability during program transitions.
  • Customer concentration and platform dependence: Loss or deferral of design wins can be difficult to offset quickly due to the engineering-intense nature of automotive adoption.
  • Technology and performance risk: Thermal systems must meet tight safety, durability, and energy-performance requirements under harsh operating conditions.
  • Capital intensity and manufacturing scaling: Capacity additions and process upgrades are required to meet customer demand and quality standards; misaligned investments can weigh on returns.
  • Input cost and supply chain volatility: Exposure to commodity-linked inputs and logistics constraints can affect margins without effective pass-through mechanisms.

📊 Valuation & Market View

The market typically values automotive component suppliers using EV/EBITDA and P/S for growth and operational leverage, while equity narratives often hinge on gross margin durability and the quality of the order/program pipeline.

Key valuation drivers for this sector include:

  • Program ramp quality (how quickly margins stabilize after launch).
  • Mix shift toward higher-value thermal features.
  • Cash flow conversion (working capital discipline and inventory management).
  • Visibility of design wins and multi-year customer platform allocation.
  • Competitive positioning (ability to win or retain content amid larger thermal-system peers).

In practice, sentiment often compresses and expands with OEM production expectations and investor confidence in the company’s ability to convert design wins into sustained volume and margin.

🔍 Investment Takeaway

Gentherm’s long-term investment case rests on automotive embedded switching costs created by design-in qualification and system integration, supported by technical differentiation and durable customer relationships. Electrification and the continued expansion of thermal content per vehicle provide a credible multi-year demand backdrop, while competitive pressure from scaled thermal peers underscores the importance of maintaining program execution discipline, margin control, and new design-win momentum.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for THRM.

gurufocus.com2026-07-31

Gentherm Inc (THRM) Shares Fall 4.1% -- What GF Score of 92 Tells Investors

On July 31, 2026, Gentherm Inc (THRM) shares fell 4.1% to a current price of $40.58. This decline adds context to the broader price performance, as THRM's share

globenewswire.com2026-07-30

Gentherm Announces Participation in J.P. Morgan Auto Conference and Seaport Annual Summer Investor Conference

Gentherm announces participation in the J.P. Morgan Auto Conference on August 13, 2026, and the Seaport Summer Investor Conference on August 18, 2026.

zacks.com2026-07-28

Should Value Investors Buy Gentherm (THRM) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

zacks.com2026-07-28

Gentherm (THRM) Shows Fast-paced Momentum But Is Still a Bargain Stock

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Gentherm (THRM) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

defenseworld.net2026-07-24

Gentherm (NASDAQ:THRM) to Repurchase $400.00 million in Stock

Gentherm (NASDAQ: THRM - Get Free Report) announced that its Board of Directors has approved a share buyback program on Thursday, July 23rd, RTT News reports. The company plans to repurchase $400.00 million in outstanding shares. This repurchase authorization allows the auto parts company to reacquire up to 36.2% of its shares through open market purchases.

seekingalpha.com2026-07-23

Gentherm Incorporated (THRM) Q2 2026 Earnings Call Transcript

Gentherm Incorporated (THRM) Q2 2026 Earnings Call Transcript

marketbeat.com2026-07-23

Gentherm Q2 Earnings Call Highlights

Gentherm NASDAQ: THRM raised its full-year 2026 outlook after reporting record quarterly product revenue and stronger-than-expected automotive demand in the second quarter, executives said on the company's earnings call.

zacks.com2026-07-23

Gentherm (THRM) Beats Q2 Earnings and Revenue Estimates

Gentherm (THRM) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.54 per share a year ago.

globenewswire.com2026-07-23

Gentherm Reports 2026 Second Quarter Results and Announces a New Increased Stock Repurchase Authorization

Revenue Growth of 9.5% (ex-FX) Year-over-Year Delivered Record Quarterly Revenue of $416 Million 2026 Full Year Guidance Raised Board Authorized New Stock Repurchase Program of up to $400 Million Strategic Medical Acquisition Broadens Product Portfolio and Expands Channel Access NOVI, Mich., July 23, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced its financial results for the second quarter ended June 30, 2026.

globenewswire.com2026-07-22

Gentherm Acquires Innovative Medical Equipment, LLC, Strengthening Medical Product Portfolio and Customer Channels

Gentherm acquires Innovative Medical Equipment, adding ThermaZone thermal therapy technology to expand its medical portfolio and growth opportunities.

defenseworld.net2026-07-22

Gentherm Inc $THRM Shares Bought by Bessemer Group Inc.

Bessemer Group Inc. boosted its holdings in shares of Gentherm Inc (NASDAQ: THRM) by 50.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 129,695 shares of the auto parts company's stock after buying an additional 43,500 shares during the quarter. Bessemer Group

globenewswire.com2026-07-20

Gentherm Medical Receives FDA Clearance for ThermAffyx™ Patient Safety System

NOVI, Mich., July 20, 2026 (GLOBE NEWSWIRE) -- Gentherm, a global market leader of innovative thermal management and pneumatic comfort technologies, announced today it received FDA 510(k) clearance for its patented  ThermAffyx™ Patient Safety System.

zacks.com2026-07-16

Gentherm (THRM) Earnings Expected to Grow: Should You Buy?

Gentherm (THRM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com2026-07-09

Are Investors Undervaluing Gentherm (THRM) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

globenewswire.com2026-07-07

Gentherm Announces Date for 2026 Second Quarter News Release and Conference Call

NOVI, Mich., July 07, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ: THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, will report its financial results for the second quarter 2026 on Thursday, July 23, 2026, and will host a conference call to discuss those results at 8 am (ET) that same day.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-30

"THRM reported Q2’26 revenue of $96.4M and net income of $4.4M (EPS $0.14), with net margin of ~4.6%. QoQ, revenue fell materially from Q1’26 ($393.7M) to Q2’26 ($96.4M; ~-75.5% QoQ), while net income edged up slightly from $4.2M to $4.4M (~+4.8% QoQ). YoY, Q2’26 revenue rose from $375.1M in Q2’25 to $96427000 (~-74.3% YoY), and net income increased sharply from $0.477M in Q2’25 to $4.42M (~+826% YoY). Profitability is mixed over the four quarters: operating income in Q2’26 is $10.7M (operating margin ~11.1%) versus Q1’26’s $11.3M but a much lower Q1 margin (~2.9%). However, the income statement line items appear volatile, so trends should be treated cautiously; the gross profit ratio in Q2’26 is anomalously reported as 1.0. Cash flow improved versus Q1’26: operating cash flow turned positive at $7.3M (from -$5.0M in Q1’26). Free cash flow was slightly negative (-$1.2M) due to capex of -$8.6M. The company holds substantial liquidity ($213M cash) and equity remains stable (~$723M), while total assets grew QoQ (~$1.49B from $1.43B). Shareholder returns look supportive: the stock is up ~25.8% over the last year (capital appreciation tailwind), and dividends/buybacks are minimal (dividends $0; buybacks $1.9M in Q2’26). Analyst sentiment implies expensive valuation versus near-term earnings (P/E ~60.9) with price targets still below current price (consensus $43.67 vs $29.77 context shown by dataset)."

Revenue Growth

Neutral

QoQ revenue declined ~-75.5% (Q1’26 $393.7M to Q2’26 $96.4M). YoY revenue is also down sharply (~-74.3% vs Q2’25 $375.1M), indicating highly unstable quarter-to-quarter demand/recognition.

Profitability

Neutral

Net income increased slightly QoQ (~+4.8%) and surged YoY (~+826%). Operating margin in Q2’26 is reported stronger (~11.1%) versus Q1’26 (~2.9%), but reported margins/gross ratio show potential data anomalies, so trend confidence is moderate.

Cash Flow Quality

Fair

Operating cash flow improved to +$7.3M from -$5.0M QoQ. Free cash flow remained slightly negative in Q2’26 (-$1.2M) but is far better than Q1’26 (-$10.7M), suggesting improving cash generation despite near-term capex pressure.

Leverage & Balance Sheet

Neutral

Liquidity improved (cash +$35.8M QoQ to $213.2M). Total assets increased QoQ (~$1.49B vs $1.43B). Total debt rose QoQ (~$325.1M vs $273.4M), but equity stayed stable (~$723M), keeping resilience reasonable.

Shareholder Returns

Positive

Total shareholder return supported by strong price momentum (+25.8% 1y_change). Dividends are $0. Buybacks are present but small (common repurchased ~$1.9M in Q2’26), so most of the return is price-driven.

Analyst Sentiment & Valuation

Neutral

Valuation appears rich versus current earnings (P/E ~60.9; operating cash flow multiple very high). Price target data in the dataset also suggests limited upside versus current price, implying cautious sentiment despite the recent run.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Gentherm’s Q2 2026 performance showed broad-based automotive momentum with record product revenue of $416M (+11% YoY) and adjusted EPS of $0.75 (+39% YoY). The key operational story is discipline: labor/equipment/utilization and inventory initiatives are improving, but Q2 adjusted EBITDA margin slipped ~50 bps to 11.7% due to inflation recovery timing, footprint inventory reductions, and warranty accruals. Management raised full-year 2026 guidance (ex-Modine): revenue midpoint $1.6B (~5% growth) and adjusted EBITDA $185M–$200M (midpoint margin ~12%), alongside $85M–$100M adjusted free cash flow. Catalysts extend beyond light vehicle: home/office deployments with 5 new customers and visibility to $50M–$100M by 2028, plus ThermAffyx FDA 510(k) clearance with initial sales expected in Q3. Business development is accelerating with the July 1 IME bolt-on acquisition ($34M purchase price) and Modine merger: early Q4 close expected, with $800M committed financing and buyback authorization of up to $400M.

AI IconGrowth Catalysts

  • Automotive: ~$690M Automotive New Business Awards in Q2; YTD >$1B; no single program/region singled out as driver
  • Automotive Climate and Comfort: Lumbar and Massage Comfort Solutions revenue up 38% YoY
  • Home/office: Thermoelectric comfort technologies deployed with 5 new customers; visibility to $50M–$100M revenue by 2028
  • Medical: FDA 510(k) clearance for ThermAffyx; producing now and in clinical trial period; expect initial sales in Q3

Business Development

  • ThermaZone therapy device via acquisition of Innovative Medical Equipment (IME) completed July 1; IME has reach into Veterans Administration hospitals and clinics
  • Home/office furniture market selections by 2 leading North American-based brands (named publicly later); prior public example was KUKA (Chinese-based manufacturer)
  • Modine Performance Technologies merger: committed financing and planned close in early Q4

AI IconFinancial Highlights

  • Revenue: $416M, up 11% YoY; up 9.5% ex-FX, driven by higher automotive volumes
  • Automotive Climate and Comfort Solutions revenue: +14.1% YoY (+12.7% ex-FX)
  • Adjusted EBITDA: $48.8M; 11.7% of sales vs 12.2% in Q2 last year (approx. -50 bps)
  • GAAP diluted EPS: $0.14 impacted by ~$0.55/share merger and restructuring expenses
  • Adjusted diluted EPS: $0.75 vs $0.54 YoY (+39%)
  • Adjusted free cash flow: ~$16M year-to-date; in line with expectations and seasonality; CapEx: $14M down $9.5M YoY
  • Guidance (ex-Modine impact): revenue midpoint $1.6B (~5% growth vs ~-3% light vehicle production forecast); adjusted EBITDA range $185M–$200M (midpoint margin ~12%)
  • Cash guidance: adjusted free cash flow $85M–$100M; CapEx $45M–$55M (~3% of sales); margin headwind in Q3 followed by rebound in Q4

AI IconCapital Funding

  • Liquidity: $502M at end of Q2; net leverage: 0.3 turns
  • Committed financing for Modine transaction: $800M total ($550M 5-year revolving credit facility + $250M term loan)
  • Post-closing leverage expectation: net leverage ~1 turn; target leverage range 1.0x–1.5x over time
  • Buyback authorization: up to $400M over 3 years (nearly 3x prior program); expectation to repurchase shares upon Modine closing

AI IconStrategy & Ops

  • Operating system/rigor: initiatives improving labor efficiency, equipment utilization, and inventory management; improving cash flow conversion foundation
  • Planned footprint-related inventory reductions and warranty accruals cited as offsetting operating leverage in Q2
  • Integration readiness: priority to have Performance Technologies operate as a stand-alone division on day 1; sign-to-close deliverables largely completed; closing expected early Q4

AI IconMarket Outlook

  • 2026 guidance raised (ex-Modine): revenue midpoint $1.6B; adjusted EBITDA $185M–$200M; adjusted free cash flow $85M–$100M
  • Margin path: lower margins in Q3, rebound in Q4
  • ThermAffyx: initial sales expected in Q3 after FDA 510(k) clearance and clinical trial period

AI IconRisks & Headwinds

  • Anticipated third-quarter margin pressure: “inflation recovery timing,” “planned footprint-related inventory reductions,” and “warranty accruals in both automotive and medical”
  • Runoff businesses create YoY headwind in second half (end-of-program impacts more in H2 than H1)
  • Warranty accrual explanation: auto-side claims increase tied to specific product and customer; robustness improvements made late last year; management does not view it as continuing run-rate

Q&A: Analyst Interest

  • Automotive outperformance sustainability: Analysts asked why Q2 beat expectations and whether the mid- to high-single-digit growth over market remains intact. Management said outperformance is broad-based across products and regions, highlighted China launches/take rates, but noted tougher comps in H2 and expects the same trajectory, though not perfectly linear.
  • IME acquisition economics and timing: Analysts requested purchase price/terms and how the $17M/20% business impacts 2026. Management confirmed $34M purchase price; described IME as a $17M growth business pro forma for the year, with profitability around 20% EBITDA and growth potential to double revenue over time, contributing in H2 per guidance.
  • ThermAffyx demand and IME cross-sell synergy: Analysts asked for early demand metrics and whether IME improves ThermAffyx/channel expectations. Management said ThermAffyx is producing, in clinical trials, and preparing to ship to hospitals over 50; demand looks strong. For IME, Veterans Administration access (200+ VA hospitals/clinics) versus near-zero current channel access was cited to enable strong cross-selling between markets.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the THRM Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for THRM.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (THRM)

© 2026 Stock Market Info — Gentherm Incorporated (THRM) Financial Profile